My PCR
Create Account
Logo PCR

21 May 2025

Mitral valve replacement and repair

Innovations in TMVR and Intrepid trial updates

Sponsored by Medtronic

Anchorperson: T. Modine
Spokesperson: R. S. von Bardeleben
SHOW MORE

Summary

This EuroPCR 2025 session highlights the evolving role of transcatheter mitral valve replacement, focusing on the clinical potential of mitral regurgitation elimination. Get an overview of the current status of the Intrepid TMVR programme, learn about the transition to the 29Fr transfemoral system, and explore how patient screening—especially in the presence of mitral annular calcification—impacts procedural planning. Real-world case reviews from the APOLLO-EU trial offer practical insights into how this next-generation system is being applied in Europe today.

Learning Objectives

  • To gain insights on the APOLLO TMVR trial
  • To better understand the treatment goals of mitral regurgitation elimination
  • To learn about early APOLLO EU trial experience and the Intrepid 29Fr TMVR system
Related Content
Mitral interventions: translating the new guidelines into practice PCR Mitral Focus Group: advancing mitral valve care Share your work at PCR-CIT China Chengdu Valves 2025
Recommended for you
What’s new in the 2025 guidance on valvular heart disease - ESC Congress 2025 Key updates in valvular heart disease management: insights from the 2025 ESC/EACTS Guidelines PCR Gulf Valves: Registrations are open!